David E. Wheadon's Trading History
| VXRTVaxart | Jul 17, 2026 | Director | Uninformative Buy | ― | $37.04K | |
| SHCSotera Health | May 27, 2026 | Director | Uninformative Buy | ― | $1.63M | |
| INDVIndivior | May 14, 2026 | Director | Uninformative Buy | ― | $1.09M | |
| KRTXKaruna Therapeutics | Mar 18, 2024 | ― | Uninformative Sell | 326.70K | $0.00 | |
| ASRTAssertio Therapeutics | Sep 29, 2020 | ― | Uninformative Buy | 32.30K | $6.72M | |
| SPTXSeaport Therapeutics, Inc. | ― | Director | ― | ― | ||
| ~CCXIChemoCentryx | ― | ― | ― | ― |
You May Also Like
David E. Wheadon insider profile FAQ
What stocks does David E. Wheadon hold?
David E. Wheadon holds: VXRT, ~CCXI, ASRT, INDV, KRTX, SHC, SPTX stocks.
What is David E. Wheadon's role in Vaxart?
David E. Wheadon's role in Vaxart is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.